Related Experiment Video

Updated: Oct 15, 2025

MAME Models for 4D Live-cell Imaging of Tumor: Microenvironment Interactions that Impact Malignant Progression
08:26

MAME Models for 4D Live-cell Imaging of Tumor: Microenvironment Interactions that Impact Malignant Progression

Published on: February 17, 2012

14.7K

MDM4 Isoform Expression in Melanoma Supports an Oncogenic Role for MDM4-A

Abdullah Alatawi1, SoonJye Kho2, Michael P Markey1

  • 1Department of Biochemistry and Molecular Biology, Wright State University, Dayton, OH 45435, USA.

Journal of Skin Cancer
|October 26, 2021
PubMed

Insights

In melanoma, the tumor suppressor p53 remains intact but is inactivated by inhibitory proteins MDM2 and MDM4. Researchers found MDM4 is often overexpressed and its splicing altered, impacting therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The p53 tumor suppressor is crucial for halting abnormal cell growth by inducing cell cycle arrest or apoptosis.
  • p53 activity is frequently lost in cancer, though its gene remains intact in most melanoma cases.
  • p53 inactivation in melanoma is primarily mediated by interaction with inhibitory proteins, not direct mutation.

Purpose of the Study:

  • To investigate the expression of MDM2 and MDM4, the main inhibitors of p53, in melanoma.
  • To determine the role of MDM4 alterations, including overexpression and splicing changes, in melanoma development.

Main Methods:

  • Analysis of MDM2 and MDM4 expression using genomic databases.
  • Examination of MDM2 and MDM4 expression in biopsy specimens.
  • Assessment of MDM4 splicing patterns in melanoma.

Main Results:

  • MDM4 was found to be frequently overexpressed in melanoma.
  • Alterations in MDM4 splicing were observed to occur frequently and early in melanomagenesis.
  • The p53 gene itself was found to be intact in 94% of human melanoma cases.

Conclusions:

  • MDM4 overexpression and altered splicing are significant mechanisms of p53 inactivation in melanoma.
  • These findings highlight the importance of considering MDM4 splicing in the development of targeted therapies for melanoma.
  • Therapeutic strategies targeting MDM2/4 proteins for melanoma must account for MDM4 splicing variations.

More Related Videos

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.0K
Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration10:43

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration

Published on: May 19, 2016

6.9K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.2K